Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
400 participants
INTERVENTIONAL
2007-07-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Antibiotics in Groin Hernioplasty
NCT07111702
Antibiotic Prophylaxis in Mesh Repair of Inguinal Hernias
NCT01264003
The Role of Antibiotic Prophylaxis in Lowering Wound Infection Rates Post-Open Repair of Primary Elective Groin Hernias in High-Risk Patients
NCT06576154
Effectiveness of Topical Antibiotic Prophylaxis in Inguinal Hernia Repair
NCT01273818
Prophylactic Antibiotic Treatment for Laparoscopic Inguinal Hernia Mesh Repair: Necessary or Not?
NCT02083939
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cont
Antibiotic: cefazolin Sodium
1g continuous IV at 30 minutes before starting operation
intervention
Antibiotic: cefazolin Sodium
1g continuous IV at 30 minutes before starting operation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotic: cefazolin Sodium
1g continuous IV at 30 minutes before starting operation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective surgery
* Must be older than 20 years of age
* Must not have any serious complication
Exclusion Criteria
* Recurrence
* Drug allergy
* Diabetes mellitus
* Malignant diseases
* Serious heart diseases
* Psychological diseases
* Pregnancy
* Have been medicated with corticosteroids
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nihon University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Takero Mazaki, MD, PhD
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nihon University School of Medicine, Department of Surgery
Tokyo, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hikari-0701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.